Tissue‐resident innate lymphoid cells in asthma
The Journal of Physiology · 2023-09 · 601 (18) · 3995-4012
DOI: 10.1113/jp284686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Physiology, online erschienen am 24.07.2023. Verfasst von Xiaoxu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Asthma, Immunity, Innate. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 145 Literaturangaben.
Abstract (Originalsprache)
Asthma is a chronic airway inflammatory disease whose global incidence increases annually. The role of innate lymphoid cells (ILCs) is a crucial aspect of asthma research with respect to different endotypes of asthma. Based on its pathological and inflammatory features, asthma is divided into type 2 high and type 2 low endotypes. Type‐2 high asthma is distinguished by the activation of type 2 immune cells, including T helper 2 (Th2) cells and ILC2s; the production of cytokines interleukin (IL)‐4, IL‐5 and IL‐13; eosinophilic aggregation; and bronchial hyper‐responsiveness. Type‐2 low asthma represents a variety of endotypes other than type 2 high endotype such as the IL‐1β/ILC3/neutrophil endotype and a paucigranulocytic asthma, which may be insensitive to corticosteroid treatment and/or associated with obesity. The complexity of asthma is due to the involvement of multiple cell types, including tissue‐resident ILCs and other innate immune cells including bronchial epithelial cells, dendritic cells, macrophages and eosinophils, which provide immediate defence against viruses, pathogens and allergens. On this basis, innate immune cells and adaptive immune cells combine to induce the pathological condition of asthma. In addition, the plasticity of ILCs increases the heterogeneity of asthma. This review focuses on the phenotypes of tissue‐resident ILCs and their roles in the different endotypes of asthma, as well as the mechanisms of tissue‐resident ILCs and other immune cells. Based on the phenotypes, roles and mechanisms of immune cells, the therapeutic strategies for asthma are reviewed. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
- Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of traditional Chinese medicine, Shandong Traditional Chinese Medicine College, YanTai, China.
ORCID-Profile: Peizheng Yan
Zitieren
APA
Wang, X., Kong, Y., Zheng, B., Zhao, X., Zhao, M., Wang, B., Liu, C., & Yan, P. (2023). Tissue‐resident innate lymphoid cells in asthma. The Journal of Physiology, 601(18), 3995-4012. https://doi.org/10.1113/jp284686
Vancouver
Wang X, Kong Y, Zheng B, Zhao X, Zhao M, Wang B, et al. Tissue‐resident innate lymphoid cells in asthma. The Journal of Physiology. 2023;601(18):3995-4012. doi:10.1113/jp284686
BibTeX
@article{Wang2023,
author = {Wang, Xiaoxu and Kong, Yue and Zheng, Bingqing and Zhao, Xiaomin and Zhao, Mingzhe and Wang, Bin and Liu, Chang and Yan, Peizheng},
title = {Tissue‐resident innate lymphoid cells in asthma},
journal = {The Journal of Physiology},
year = {2023},
volume = {601},
number = {18},
pages = {3995--4012},
doi = {10.1113/jp284686}
}
EUVIMED